The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol
- PMID: 2996495
- PMCID: PMC1152585
- DOI: 10.1042/bj2300053
The purification and properties of human liver ketohexokinase. A role for ketohexokinase and fructose-bisphosphate aldolase in the metabolic production of oxalate from xylitol
Abstract
Ketohexokinase (EC 2.7.1.3) was purified to homogeneity from human liver, and fructose-bisphosphate aldolase (EC 4.1.2.13) was partially purified from the same source. Ketohexokinase was shown, by column chromatography and polyacrylamide-gel electrophoresis, to be a dimer of Mr 75000. Inhibition studies with p-chloromercuribenzoate and N-ethylmaleimide indicate that ketohexokinase contains thiol groups, which are required for full activity. With D-xylulose as substrate, ketohexokinase and aldolase can catalyse a reaction sequence which forms glycolaldehyde, a known precursor of oxalate. The distribution of both enzymes in human tissues indicates that this reaction sequence occurs mainly in the liver, to a lesser extent in the kidney, and very little in heart, brain and muscle. The kinetic properties of ketohexokinase show that this enzyme can phosphorylate D-xylulose as readily as D-fructose, except that higher concentrations of D-xylulose are required. The kinetic properties of aldolase show that the enzyme has a higher affinity for D-xylulose 1-phosphate than for D-fructose 1-phosphate. These findings support a role for ketohexokinase and aldolase in the formation of glycolaldehyde. The effect of various metabolites on the activity of the two enzymes was tested to determine the conditions that favour the formation of glycolaldehyde from xylitol. The results indicate that few of these metabolites affect the activity of ketohexokinase, but that aldolase can be inhibited by several phosphorylated compounds. This work suggests that, although the formation of oxalate from xylitol is normally a minor pathway, under certain conditions of increased xylitol metabolism oxalate production can become significant and may result in oxalosis.
Similar articles
-
Models for the metabolic production of oxalate from xylitol in humans: a role for fructokinase and aldolase.Aust J Exp Biol Med Sci. 1982 Feb;60(Pt 1):117-22. doi: 10.1038/icb.1982.11. Aust J Exp Biol Med Sci. 1982. PMID: 6284103
-
The metabolic production of oxalate from xylitol: activities of transketolase, transaldolase, fructokinase and aldolase in liver, kidney, brain, heart and muscle in the rat, mouse, guinea pig, rabbit and human.Int J Vitam Nutr Res Suppl. 1985;28:29-46. Int J Vitam Nutr Res Suppl. 1985. PMID: 3009653 No abstract available.
-
The involvement of liver fructokinase in the metabolism of D-xylulose and xylitol in isolated rat hepatocytes.J Nutr. 1983 Mar;113(3):522-30. doi: 10.1093/jn/113.3.522. J Nutr. 1983. PMID: 6298387
-
Fructose Metabolism in Cancer: Molecular Mechanisms and Therapeutic Implications.Int J Med Sci. 2025 Jun 9;22(11):2852-2876. doi: 10.7150/ijms.108549. eCollection 2025. Int J Med Sci. 2025. PMID: 40520908 Free PMC article. Review.
-
Control of hepatic fructose-metabolizing enzymes: fructokinase, aldolase and triokinase.Acta Med Scand Suppl. 1972;542:47-56. doi: 10.1111/j.0954-6820.1972.tb05318.x. Acta Med Scand Suppl. 1972. PMID: 4579754 Review. No abstract available.
Cited by
-
Bypassing the Pentose Phosphate Pathway: Towards Modular Utilization of Xylose.PLoS One. 2016 Jun 23;11(6):e0158111. doi: 10.1371/journal.pone.0158111. eCollection 2016. PLoS One. 2016. PMID: 27336308 Free PMC article.
-
Dynamics and control of the central carbon metabolism in hepatoma cells.BMC Syst Biol. 2010 Apr 28;4:54. doi: 10.1186/1752-0509-4-54. BMC Syst Biol. 2010. PMID: 20426867 Free PMC article.
-
Expression of rat liver ketohexokinase in yeast results in fructose intolerance.Biochem J. 1993 Apr 1;291 ( Pt 1)(Pt 1):179-86. doi: 10.1042/bj2910179. Biochem J. 1993. PMID: 8471037 Free PMC article.
-
Intracellular Toxic Advanced Glycation End-Products May Induce Cell Death and Suppress Cardiac Fibroblasts.Metabolites. 2022 Jul 1;12(7):615. doi: 10.3390/metabo12070615. Metabolites. 2022. PMID: 35888739 Free PMC article.
-
Exploring Marine-Derived Compounds: In Silico Discovery of Selective Ketohexokinase (KHK) Inhibitors for Metabolic Disease Therapy.Mar Drugs. 2024 Oct 3;22(10):455. doi: 10.3390/md22100455. Mar Drugs. 2024. PMID: 39452863 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases